Zurcher Kantonalbank Zurich Cantonalbank raised its position in Cigna Corporation (NYSE:CI) by 29.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 114,193 shares of the health services provider’s stock after acquiring an additional 25,981 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Cigna were worth $21,347,000 at the end of the most recent quarter.
A number of other large investors have also recently modified their holdings of the business. Spot Trading L.L.C. raised its stake in shares of Cigna by 108.9% during the first quarter. Spot Trading L.L.C. now owns 1,998 shares of the health services provider’s stock valued at $293,000 after purchasing an additional 24,425 shares in the last quarter. Financial Architects Inc raised its position in Cigna by 186.0% in the second quarter. Financial Architects Inc now owns 1,121 shares of the health services provider’s stock worth $188,000 after acquiring an additional 729 shares in the last quarter. Quantitative Systematic Strategies LLC raised its position in Cigna by 267.4% in the second quarter. Quantitative Systematic Strategies LLC now owns 13,955 shares of the health services provider’s stock worth $2,326,000 after acquiring an additional 10,157 shares in the last quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH bought a new stake in Cigna in the second quarter worth about $4,205,000. Finally, PGGM Investments bought a new stake in Cigna in the second quarter worth about $21,588,000. 87.85% of the stock is owned by institutional investors.
A number of brokerages recently weighed in on CI. Morgan Stanley lifted their price target on Cigna from $195.00 to $223.00 and gave the stock an “overweight” rating in a research note on Friday, November 3rd. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $220.00 target price (up previously from $185.00) on shares of Cigna in a research note on Friday, November 3rd. Jefferies Group lifted their target price on Cigna from $201.00 to $221.00 and gave the company a “buy” rating in a research note on Friday, October 13th. Credit Suisse Group began coverage on Cigna in a report on Thursday, November 2nd. They set an “outperform” rating and a $219.00 price target for the company. Finally, Citigroup lifted their price target on Cigna from $198.00 to $231.00 and gave the company a “buy” rating in a report on Friday, November 3rd. Three equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. Cigna has a consensus rating of “Buy” and a consensus target price of $201.50.
Shares of Cigna Corporation (NYSE:CI) traded up $1.79 during mid-day trading on Thursday, hitting $206.00. The stock had a trading volume of 980,132 shares, compared to its average volume of 1,352,227. The company has a quick ratio of 0.39, a current ratio of 0.39 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $50,325.72, a PE ratio of 19.67, a PEG ratio of 1.56 and a beta of 0.50. Cigna Corporation has a 12 month low of $131.03 and a 12 month high of $212.46.
Cigna (NYSE:CI) last announced its earnings results on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, topping the consensus estimate of $2.36 by $0.47. The company had revenue of $10.38 billion for the quarter, compared to analysts’ expectations of $10.17 billion. Cigna had a return on equity of 18.85% and a net margin of 5.74%. The business’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.94 earnings per share. equities research analysts forecast that Cigna Corporation will post 10.34 earnings per share for the current year.
In other Cigna news, EVP Alan Muney sold 15,345 shares of the firm’s stock in a transaction that occurred on Monday, November 27th. The stock was sold at an average price of $200.80, for a total value of $3,081,276.00. Following the completion of the transaction, the executive vice president now directly owns 28,457 shares in the company, valued at $5,714,165.60. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Chairman Isaiah Harris, Jr. sold 247 shares of the firm’s stock in a transaction that occurred on Tuesday, September 12th. The shares were sold at an average price of $185.27, for a total value of $45,761.69. The disclosure for this sale can be found here. Insiders have sold 36,203 shares of company stock worth $7,211,251 in the last ninety days. 1.30% of the stock is currently owned by insiders.
COPYRIGHT VIOLATION WARNING: This article was first posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.thelincolnianonline.com/2017/12/08/zurcher-kantonalbank-zurich-cantonalbank-raises-stake-in-cigna-corporation-ci-updated-updated.html.
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.